EnvisionX Capital Research
Investment Thesis
EnvisionX Capital is an early growth-stage venture capital fund based in Palo Alto, California, founded in January 2023 by Holly Zheng (former CEO of BlueFocus International, a major Chinese marketing and advertising firm) together with He Shen and George Maloney as partners. David Wei, the ex-Alibaba.com CEO and founding partner of Vision Knight Capital, chairs the firm's advisory board, focused mainly on compliance. Despite the founders' China-market backgrounds, EnvisionX is structured as a standalone, US-based GP with LPs that mostly have no ties to China. The firm's thesis centers on backing technology-driven, revenue-positive companies with global ambitions, combining operational expertise (talent sourcing, sales strategy, market entry, brand storytelling) with capital-markets experience to help portfolio companies expand into the U.S. and international markets. On AI specifically, the team has articulated a "human-in-the-loop" view: generative AI should amplify, not replace, human capability, and enterprise moats matter more than raw automation.
Sector Focus
EnvisionX targets artificial intelligence, enterprise SaaS, healthcare/digital health, robotics, fintech, cybersecurity, and smart hardware/digital infrastructure, spanning both infrastructure and application layers. AI is the dominant through-line across the portfolio: contact-center AI (Cresta), medical-text AI (ScienceIO), AI-native media search (Clipto AI), AI data-center connectivity hardware (XConn Technologies), and AI infrastructure/search for agents (Cloudsway AI).
Stage Focus
The firm invests at early growth stage: seed-plus through Series A, with occasional participation up to Series B for existing portfolio companies with strong traction (e.g., Cresta's $125M Series D). EnvisionX looks for companies that already have product-market traction and initial revenue rather than pure pre-product bets.
Check Size
Equity checks typically start at $1M-$2M for pre-Series A rounds and can occasionally reach up to $10M at the Series B stage, broadly consistent with third-party guide estimates of a $1M-$5M sweet spot.
Lead Tendency
EnvisionX is generally a participant rather than a lead investor. Per managing partner Holly Zheng, the firm has had opportunities to lead some deals but has chosen not to, partly to mitigate regulatory risk given the founders' cross-border backgrounds, while still remaining an active, high-conviction investor.
Recent Activity
The firm closed its $100M debut fund in April 2023 and has made at least eleven direct investments since inception. It remains actively deploying and monitoring portfolio milestones:
- November 2024: Participated in Cresta's $125M Series D (new investors included Accenture, LG Technology Ventures, Qualcomm, and Workday Ventures; re-ups from a16z, Greylock, J.P. Morgan, Sequoia, and Tiger Global).
- September 2024: Participated in Bot Auto's oversubscribed $20M pre-Series A round for Level 4 autonomous trucking.
- February 2024: Portfolio company ScienceIO was acquired by Veradigm for $140M.
- January 2026: Portfolio company XConn Technologies (CXL/PCIe switch silicon) was acquired by Marvell Technology for approximately $540M.
- August 2026: Portfolio company Clipto AI reached a $250M valuation after hitting $15M ARR and profitability, raising a further $15M round.
Portfolio Highlights
Core EnvisionX Capital fund investments include ScienceIO (acquired by Veradigm, 2024), StreamNative (cloud-native data streaming), Subtle Medical (healthcare imaging AI), Bot Auto (Level 4 autonomous trucking), Cresta (contact-center generative AI, >$270M raised to date), Viso Trust (third-party cyber risk assessment), XConn Technologies (acquired by Marvell, 2026, ~$540M), BentoML (ML model serving framework), Artera AI (AI-driven healthcare), Clipto AI (AI media search, $250M valuation), and Cloudsway AI (AI agent infrastructure and search). Separately, the firm's website also lists companies invested in by individual EnvisionX team members prior to or outside the fund (e.g., Bolt, AiFi, Anker, Amprius, Pop Mart, HireEZ, Tripalink, Intervenn, Smoore, Hisense Broadband); these reflect the team's personal/prior track record rather than EnvisionX Capital fund investments and are not included in the fund's portfolio list.
Team
- Holly Zheng, Founding & Managing Partner: Former CEO of BlueFocus International (major Chinese marketing/advertising agency); led its international expansion. Brings operational management and venture experience to portfolio support.
- He Shen, Partner: Background in venture investing, focused on identifying and supporting high-growth startups.
- George Maloney, Partner: One of the firm's founding partners per deal-press coverage.
- David Wang, Investment Director: Focuses on investment analysis and portfolio management for technology-driven companies.
- Henry Wang, Investment Director: Evaluates investment opportunities across the technology portfolio.
- Ivy Zhou, Associate: Supports the investment team.
- David Wei, Chairman, Advisory Board: Ex-CEO of Alibaba.com and founding partner/chairman of Vision Knight Capital; chairs EnvisionX's advisory board, addressing mainly compliance matters. EnvisionX and Vision Knight share a founder and some LPs but are legally and operationally separate firms.
Decision Process
EnvisionX operates as a multi-partner partnership (Zheng, Shen, Maloney) rather than a solo-GP structure, with an advisory board chaired by David Wei handling compliance oversight.
Founder Preferences
The firm favors technical, execution-focused founders building product-driven, technically differentiated companies that are already revenue-positive and have clear global (especially U.S.) expansion ambitions. Many portfolio founders have cross-border (US/China) backgrounds and postgraduate technical training.
Geographic Focus
EnvisionX is a U.S.-structured fund headquartered in Palo Alto, California, investing primarily in North America while leveraging the team's global (including Asia) network and connections for sourcing and portfolio support.